Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial-Reference-Cited by-同舟云学术

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial

Published:2024-07 Issue:7 Volume:11 Page:e499-e509
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Pulsoni Alessandro,Ferrero Simone,Tosti Maria Elena,Luminari Stefano,Dondi Alessandra,Cavallo Federica,Merli Francesco,Liberati Anna Marina,Cenfra Natalia,Renzi Daniela,Zanni Manuela,Boccomini Carola,Ferreri Andrés J M,Rattotti Sara,Zilioli Vittorio Ruggero,Bolis Silvia Anna,Bernuzzi Patrizia,Musuraca Gerardo,Gaidano Gianluca,Perrone Tommasina,Stelitano Caterina,Tucci Alessandra,Corradini Paolo,Bigliardi Sara,Re Francesca,Cencini Emanuele,Mannarella Clara,Mannina Donato,Celli Melania,Tani Monica,Annechini Giorgia,Assanto Giovanni Manfredi,Grapulin Lavinia,Guarini Anna,Cavalli Marzia,De Novi Lucia Anna,Bomben Riccardo,Ciabatti Elena,Genuardi Elisa,Drandi Daniela,Della Starza Irene,Arcaini Luca,Ricardi Umberto,Gattei Valter,Galimberti Sara,Ladetto Marco,Foà Robin,Del Giudice Ilaria

Funder

GlaxoSmithKline Inc

Novartis International AG

Publisher

Elsevier BV

Reference33 articles.

1. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dreyling;Ann Oncol,2021

2. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG);Specht;Int J Radiat Oncol Biol Phys,2014

3. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University;Mac Manus;J Clin Oncol,1996

4. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial;Lowry;Radiother Oncol,2011

5. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas;Teeling;Blood,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in early-stage follicular lymphoma: TROG99.03;2024-08-11

2. Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma;The Lancet Haematology;2024-07